Tafro syndrome: early combination therapy outcomes and prolonged thrombocytopenia—a seven-case series
Thrombocytopenia in TAFRO syndrome persists long term despite intensive combination therapy. Early combination therapy was associated with excellent survival outcomes, suggesting that intensifying treatment solely for thrombocytopenia may not be necessary given its prolonged course.
Authors
- Nobushiro Nishimura (ORCID: https://orcid.org/0000-0001-5163-0481)
- H Kawashima (ORCID: https://orcid.org/0000-0001-9345-0665)
- Shiro Ono (ORCID: https://orcid.org/0000-0002-8956-2725)
- Kiyomi Yoshimoto (ORCID: https://orcid.org/0000-0001-5823-8239)
- Ryo Yoneima (ORCID: https://orcid.org/0000-0002-0382-7498)
- Masaki Matsubara (ORCID: https://orcid.org/0000-0002-6337-3280)
- Makiko Miyamoto (ORCID: https://orcid.org/0000-0001-8306-0460)
- Noritaka Yada (ORCID: https://orcid.org/0000-0002-8434-7399)
- Tomohiro Nakamura (ORCID: https://orcid.org/0000-0003-0051-2033)
- Hidetoshi Matsuoka
Institutions
- Nara Medical University Hospital (JP)
- Nara Medical University (JP)
Publication Details
- Journal
- Modern Rheumatology
- Published
- 2025-10-08
- DOI
- https://doi.org/10.1093/mr/roaf092
- Citations
- 1
- Primary Topic
- Parvovirus B19 Infection Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.40